CLRO Stock Explodes 101% on Cortigent Reverse Merger: Is ClearOne Becoming a Brain-Computer Interface Stock?
Key Takeaways ClearOne (NASDAQ: CLRO) surged more than 100% after announcing a merger agreement with Cortigent, a wholly owned subsidiary of Vivani Medical. The move was not driven by a recovery in ClearOne’s legacy conferencing or AV business. Instead, CLRO stock jumped because investors are now pricing in a potential reverse merger into a brain-computer … Read more